Skip to main content
. Author manuscript; available in PMC: 2009 Oct 5.
Published in final edited form as: Chest. 2008 Jul 18;134(6):1162–1168. doi: 10.1378/chest.08-0346

Table 1.

Baseline Characteristics of Participants*

Characteristics Bilevel Group (n = 13) CPAP Group (n = 11) 95% CI for Difference
LVEF, % 26.0 (2.7) 29.0 (2.9) − 5.3, 11.3
BMI, kg/m2 35 (1.6) 32 (1.8) − 8.5, 1.6
Baseline AHI, events/h 33 (4.5) 30 (4.9) − 17.9, 9.6
ESS score 11.8 (1.8) 13.5 (1.8) − 3.5, 7.1
Age, yr 51.3 (2.7) 54.8 (3.0) − 4.9, 11.9
Baseline systolic BP, mm Hg 115 (4.8) 110 (5.2) − 19.7, 9.6
Baseline diastolic BP, mm Hg 68 (3.3) 68 (3.6) − 10.0, 10.0
Baseline heart rate, beats/min 74 (3.8) 73 (3.4) − 12.3, 9.3
Type of cardiomyopathy: dilated/ischemic/other 8/2/3 7/4/0
Patients receiving β-blockers: carvedilol/metoprolol 9/4 9/2
Patients receiving angiotensin-converting enzyme or
  angiotensin inhibitors
13 11
Patients receiving spironolactone 6 5
*

Data are presented as mean (SE) or No. unless otherwise indicated.